Stockscreener 앱 받기
0.8334
55.43%
-1.0366
시간 외 거래:
.84
0.0066
+0.79%
전일 마감가:
$1.87
열려 있는:
$0.9
하루 거래량:
9.50M
Relative Volume:
24.03
시가총액:
$4.87M
수익:
-
순이익/손실:
$-22.76M
주가수익비율:
-0.0909
EPS:
-9.1712
순현금흐름:
$-27.90M
1주 성능:
-68.55%
1개월 성능:
-83.63%
6개월 성능:
-84.37%
1년 성능:
-96.11%
1일 변동 폭
$0.6697
$0.9435
1주일 범위
$0.6697
$2.7127
52주 변동 폭
$0.6697
$23.40
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
명칭
Reviva Pharmaceuticals Holdings Inc
전화
(408) 501-8881
주소
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.8334 | 10.93M | 0 | -22.76M | -27.90M | -9.1712 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-05 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-09-29 | 개시 | Chardan Capital Markets | Buy |
| 2023-09-20 | 개시 | ROTH MKM | Buy |
| 2023-06-08 | 개시 | The Benchmark Company | Speculative Buy |
| 2022-01-24 | 개시 | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc 주식(RVPH)의 최신 뉴스
Reviva Pharmaceuticals Announces $10 Million Equity Offering - TipRanks
Reviva Pharmaceuticals (NASDAQ: RVPH) raises equity with detachable warrants and pre‑funded options - Stock Titan
Reviva (NASDAQ: RVPH) prices $10M equity deal to fund Phase 3 trial - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
What's Behind The Drop In Reviva Pharmaceuticals Stock? - Benzinga
Dow Falls Over 300 Points; US Initial Jobless Claims Fall - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
$10M raise backs Reviva's Phase 3 schizophrenia drug trial - Stock Titan
Reviva Pharmaceuticals prices $10M public offering at $1.50 By Investing.com - Investing.com India
Reviva Pharmaceuticals announces public stock and warrant offering By Investing.com - Investing.com South Africa
Why Did RVPH Stock Crash 40% In Pre-Market Today? - Stocktwits
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - GlobeNewswire
Reviva Pharmaceuticals announces pricing of $10 million public offering at $1.50 per share - marketscreener.com
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - Benzinga
Reviva Pharmaceuticals announces public stock and warrant offering - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Reviva Pharmaceuticals (NASDAQ: RVPH) proposes sale of stock, warrants to fund Phase 3 - Stock Titan
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewswire
Reviva seeks fresh cash for Phase 3 schizophrenia trial - Stock Titan
Gainers Report: Is now the right time to enter Reviva Pharmaceuticals Holdings IncQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Setup Watch: Should I hold or sell Conduit Pharmaceuticals Inc now2026 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Value Recap: What makes Reviva Pharmaceuticals Holdings Inc stock attractive todayGDP Growth & AI Based Trade Execution Alerts - baoquankhu1.vn
Breakout Watch: How correlated is Reviva Pharmaceuticals Holdings Inc to the S P5002026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Volume Summary: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentInflation Watch & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 - Investing.com Nigeria
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold By Investing.com - Investing.com Nigeria
Reviva Pharmaceuticals Holdings Inc NPV Share Price - Hargreaves Lansdown
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears - TechStock²
HC Wainwright & Co. Maintains Reviva Pharmaceuticals Holdings (RVPH) Buy Recommendation - MSN
US Market Wrap: Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Reviva Pharmaceuticals Announces Major Share Consolidation Plan - AD HOC NEWS
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reacts to inflationary pressures2025 Pullback Review & Weekly High Potential Stock Alerts - Naître et grandir
CEO Moves: Is now the right time to enter Reviva Pharmaceuticals Holdings Inc2025 Market WrapUp & Risk Controlled Swing Alerts - baoquankhu1.vn
Reviva Pharmaceuticals (RVPH) Downgraded to Hold by D. Boral Cap - GuruFocus
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold - Investing.com
Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split - TipRanks
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 By Investing.com - Investing.com India
D Boral Capital downgrades Reviva Pharmaceuticals Holdings (RVPH) - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
RVPH PE Ratio & Valuation, Is RVPH Overvalued - Intellectia AI
Risks Report: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channel2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn
Rate Hike: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant stock outperform in a bear marketShort Setup & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Levels Update: Will Reviva Pharmaceuticals Holdings Inc benefit from sector rotationJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Sentiment: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflation2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Trade Report: Is Reviva Pharmaceuticals Holdings Inc exposed to currency risks2025 Price Momentum & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Guidance Update: Is Reviva Pharmaceuticals Holdings Inc forming a bullish divergenceJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
Earnings Beat: Does Flywire Corporation stock have upside surprise potentialJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail
What technical signals suggest for Reviva Pharmaceuticals Holdings Inc. stockJuly 2025 Market Mood & Real-Time Market Trend Scan - mfd.ru
Loss Report: Is ProShares Trust ProShares UltraPro MidCap400 stock forming a cup and handle2025 Volume Leaders & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Reviva Pharmaceuticals Holdings Inc (RVPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):